Fizazi, et al. ARAMIS: Efficacy and safety of darolutamide in nonmetastatic castration-resistant prostate cancer (nmCRPC). ASCO-GU 2019, abstract 140.
‘De werk-privé balans is beter, maar de zorg is stroperiger’
mei 2024
mrt 2024
nov 2023
sep 2023